Today: 9 April 2026
SoFi stock jumps into 2026 as Jan. 30 earnings date lands on calendar — what to watch next
5 January 2026
1 min read

SoFi stock jumps into 2026 as Jan. 30 earnings date lands on calendar — what to watch next

NEW YORK, January 4, 2026, 18:43 ET — Market closed

  • SoFi set Jan. 30 for fourth-quarter and full-year 2025 results, with a morning earnings release and conference call
  • Shares last closed up 4.9% at $27.46 after a wide intraday range and heavy volume
  • Traders eye U.S. jobs data and the Fed’s late-January meeting ahead of the report

SoFi Technologies (SOFI) set Jan. 30 for its fourth-quarter and full-year 2025 results, giving investors a fresh catalyst after the stock ended the first session of 2026 up 4.9% at $27.46. SoFi Investors

The timing matters because SoFi has become a high-beta read on how markets are pricing consumer credit, growth stocks and the path of U.S. interest rates. The stock’s big daily swings can draw short-term traders, while long-only investors tend to anchor to the next earnings print.

The run into late January also overlaps with market-moving macro events, including the U.S. employment report on Jan. 9 and the Federal Reserve’s Jan. 27–28 policy meeting. Both can shift rate expectations that ripple into fintech valuations and funding costs. Bureau of Labor Statistics

SoFi said it plans to release results at about 7 a.m. ET on Jan. 30, followed by an 8 a.m. conference call. The company straddles lending, consumer financial products and a technology platform that sells banking infrastructure to other firms.

Fintech shares were not uniformly higher into the turn of the year. Robinhood Markets gained about 1.9% on Friday, while buy-now-pay-later lender Affirm slipped about 0.5%, underscoring that stock-specific catalysts can still dominate day-to-day moves.

Analyst views remain split, with valuation a recurring fault line. JPMorgan’s Reginald Smith kept a Hold rating and cited a “soft-landing grind” outlook for fintech in 2026, according to a TipRanks recap that also pegged the average price target around $27.50. TipRanks

SoFi last raised its full-year outlook after posting record third-quarter results, leaning on fee-based revenue while expanding lending, Reuters reported in October. At the time, the company forecast 2025 adjusted earnings per share of about 37 cents. Reuters

For the Jan. 30 report, investors will focus on loan growth and credit trends, including whether delinquencies and charge-offs stay contained as the cycle turns. They will also listen for any shift in margin commentary — the spread between what a lender earns on loans and what it pays on deposits.

Technically, SoFi sits in a 52-week range of $8.60 to $32.73, leaving it about 16% below the high even after Friday’s rebound. The stock ended the week just under $27.50, a level traders often treat as a near-term pivot. Investing

The risk is that macro data or management commentary forces a reset: higher funding costs, weaker credit performance or softer-than-expected outlook language can hit rate-sensitive growth names quickly. With the Fed meeting two days before SoFi reports, that window could amplify volatility.

Next up is the U.S. jobs report on Jan. 9, then the Fed’s Jan. 27–28 meeting, before SoFi’s Jan. 30 results put the company’s 2026 trajectory back in focus.

Stock Market Today

  • Guard Therapeutics Faces Potential Delisting from Nasdaq First North Growth Market
    April 9, 2026, 12:06 PM EDT. Guard Therapeutics International AB has been notified by Nasdaq that it currently fails to meet the active operations requirement, risking delisting by June 17, 2026. The company is exploring a merger or reverse acquisition to satisfy Nasdaq's operational criteria. A transaction structure is expected to be proposed in Q2 2024, allowing Nasdaq to reassess the listing status. If no agreement is reached, the board will recommend voluntary delisting and liquidation, returning available funds to shareholders. Final decisions will be taken by shareholders at a general meeting. Guard Therapeutics focuses on developing therapies for kidney diseases based on the alpha-1-microglobulin protein and is listed under the ticker GUARD.

Latest article

Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

9 April 2026
Palantir Technologies dropped about 7% Thursday after Michael Burry said Anthropic was overtaking it in enterprise AI, putting Palantir on track to lose $34 billion in market value. Anthropic reported its annualized revenue run rate had surged past $30 billion and launched new AI tools for businesses. Nearly one in four businesses on Ramp now pays for Anthropic, according to Ramp data. Palantir’s stock still trades at 395 times earnings.
Salesforce Stock Hits Fresh 52-Week Low Despite AI Growth and $50 Billion Buyback

Salesforce Stock Hits Fresh 52-Week Low Despite AI Growth and $50 Billion Buyback

9 April 2026
Salesforce shares hit a new 52-week low Thursday, dropping 3.7% to $169.76 despite reporting 12% revenue growth and strong demand for its AI products. The broader software sector continued to slide, with the S&P 500 software and services index down about $1 trillion since January. Salesforce raised its buyback authorization to $50 billion and increased its dividend to 44 cents a share.
ServiceNow Stock Hits Fresh 52-Week Low as Analysts Cut Targets Ahead of Earnings

ServiceNow Stock Hits Fresh 52-Week Low as Analysts Cut Targets Ahead of Earnings

9 April 2026
ServiceNow shares dropped 5.1% to $92.45 by 10:20 a.m. EDT Thursday, hitting a new 52-week low after analysts at Stifel, BTIG, and Goldman Sachs cut price targets citing weak federal spending and limited 2026 growth. The company announced it will integrate AI, data, security, and governance into all products ahead of first-quarter results due April 22.
SoFi Technologies Stock Slips as Wall Street Cuts Targets Ahead of Q1 Earnings

SoFi Technologies Stock Slips as Wall Street Cuts Targets Ahead of Q1 Earnings

9 April 2026
SoFi Technologies shares fell 1.9% to $16.18 Thursday after KBW and Wells Fargo cut price targets ahead of first-quarter results due April 29. The moves follow Muddy Waters’ short position and claims of accounting issues, which SoFi denies. Affirm and LendingClub also traded lower. Barclays and other banks have trimmed targets as concerns mount over credit quality and sector valuations.
Tesla revives cheaper EV bet with compact SUV plan in China after sales strain

Tesla revives cheaper EV bet with compact SUV plan in China after sales strain

9 April 2026
Tesla is developing a smaller, cheaper electric SUV to be built first in Shanghai, sources said. The new model would cost less than the Model 3 and be smaller than the Model Y. Tesla produced 408,386 vehicles but delivered only 358,023 in Q1, as U.S. demand weakened and competition increased. Shares fell 0.8% Thursday.
AST SpaceMobile stock jumps 15% as BlueBird 7 reaches Florida; what to watch next
Previous Story

AST SpaceMobile stock jumps 15% as BlueBird 7 reaches Florida; what to watch next

Walmart stock near 52-week highs as 2026 opens — jobs data and Feb. 19 earnings are the next tests
Next Story

Walmart stock near 52-week highs as 2026 opens — jobs data and Feb. 19 earnings are the next tests

Go toTop